Deborah C.  Jackson net worth and biography

Deborah Jackson Biography and Net Worth

Director of American Well
In 2011, Deborah C. Jackson became the President of Cambridge College, bringing to the institution decades of leadership expertise from a number of Boston’s leading institutions. She had previously served for nearly a decade as CEO of the American Red Cross of Eastern Massachusetts. Prior to that, she was vice president of the Boston Foundation and senior vice president at Boston Children’s Hospital. She spent a decade early in her career at one of the country’s leading research and consulting firms, Abt Associates, where she served as the Deputy Director of its Healthcare and Income Security Group.

Throughout her career, Ms. Jackson has served on numerous boards and commissions including serving on the Mayor’s Task Force on Healthcare Disparities as Co‑Chair, the Group Insurance Commission of the Commonwealth of Massachusetts, the Board of Directors of Harvard Pilgrim Health Care, and the National Association of Corporate Directors. She currently serves as the Lead Director of Eastern Bank Corporation and is a board member of the Eastern Bank Charitable Foundation and serves on the boards of John Hancock Investments and the Massachusetts Women’s Forum.

Ms. Jackson attended Hampton University and completed her undergraduate studies at Northeastern University. She attended graduate school at the Massachusetts Institute of Technology in the Department of Urban Studies and Planning and attended the Harvard University Advanced Leadership Institute. She is the recipient of honorary doctorate degrees from Curry College and Merrimack Valley College.

What is Deborah C. Jackson's net worth?

The estimated net worth of Deborah C. Jackson is at least $73,176.66 as of November 2nd, 2023. Ms. Jackson owns 135,112 shares of American Well stock worth more than $73,177 as of April 23rd. This net worth evaluation does not reflect any other assets that Ms. Jackson may own. Learn More about Deborah C. Jackson's net worth.

How do I contact Deborah C. Jackson?

The corporate mailing address for Ms. Jackson and other American Well executives is 75 STATE STREET 26TH FLOOR, Boston MA, 02109. American Well can also be reached via phone at 617-204-3500 and via email at [email protected]. Learn More on Deborah C. Jackson's contact information.

Has Deborah C. Jackson been buying or selling shares of American Well?

Deborah C. Jackson has not been actively trading shares of American Well over the course of the past ninety days. Most recently, Deborah C. Jackson sold 2,376 shares of the business's stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $1.24, for a transaction totalling $2,946.24. Following the completion of the sale, the director now directly owns 135,112 shares of the company's stock, valued at $167,538.88. Learn More on Deborah C. Jackson's trading history.

Who are American Well's active insiders?

American Well's insider roster includes Keith Anderson (CFO), Bradford Gay (VP), Amber Howe (Insider), Deborah Jackson (Director), Kurt Knight (COO), Serkan Kutan (CTO), Paul McNeice (VP), Jason Medeiros (Insider), Mary Modahl (CMO), Brendan O'Grady (Insider), Deval Patrick (Director), Ido Schoenberg (CEO), and Roy Schoenberg (CEO). Learn More on American Well's active insiders.

Are insiders buying or selling shares of American Well?

During the last twelve months, insiders at the sold shares 52 times. They sold a total of 2,197,463 shares worth more than $3,135,182.65. The most recent insider tranaction occured on April, 1st when CAO Paul Francis Mcneice sold 761 shares worth more than $585.97. Insiders at American Well own 12.9% of the company. Learn More about insider trades at American Well.

Information on this page was last updated on 4/1/2024.

Deborah C. Jackson Insider Trading History at American Well

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/2/2023Sell2,376$1.24$2,946.24135,112View SEC Filing Icon  
1/20/2022Sell2,377$4.41$10,482.57View SEC Filing Icon  
See Full Table

Deborah C. Jackson Buying and Selling Activity at American Well

This chart shows Deborah C Jackson's buying and selling at American Well by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

American Well Company Overview

American Well logo
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $0.54
Low: $0.54
High: $0.59

50 Day Range

MA: $0.88
Low: $0.51
High: $1.31

2 Week Range

Now: $0.54
Low: $0.50
High: $2.74

Volume

2,396,099 shs

Average Volume

1,944,208 shs

Market Capitalization

$156.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1